Company intelligence / Profile preview

PHT Corporation

Ownership: Private
Development stage: Other

Overview

PHT Corporation was the market leader in electronic patient reported outcome (ePRO) solutions, supporting over 400 global clinical trials with more than 100 biopharmaceutical clients. Its platforms enabled high-quality, time-stamped assessments from patients worldwide and were successfully used in at least 12 NDA submissions and seven approvals. The company was acquired by ERT in 2015 to strengthen ERT’s leadership position in eClinical Outcome Assessments. ERT itself later rebranded as Clario.

Therapeutic areas: Other
Modalities: Non-pharmacological therapy
Industry: Contract Research Organization

Partnerships

CMIC Group (Japan’s first CRO)Numerous partnerships with top pharmaceutical companies as customers/users

Beyond the preview

Go deeper on PHT Corporation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PHT Corporation.

Explore the full profile